-
Je něco špatně v tomto záznamu ?
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma
T. Fenclova, F. Marecek, I. Hrachovinova
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- hemokoagulace MeSH
- hemostatika * MeSH
- krevní plazma * MeSH
- lidé MeSH
- parciální tromboplastinový čas MeSH
- vyšetření krevní srážlivosti MeSH
- zmrazování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: Degradation of coagulation proteins in frozen plasma may influence assay results. The aims of this study were to explore the changes in coagulation parameters in patient plasma and internal quality control (IQC) after different freezing and storage conditions during the short-term and long-term periods. METHODS: Platelet poor plasma was prepared from citrated peripheral blood collected from a group of healthy donors. The plasma was pooled, frozen and stored in a variety of freezing and storage conditions. The changes were monitored using routine coagulation assays, as well as factor VIII (FVIII) and protein S (PS) assays. RESULTS: Plasma stored in liquid nitrogen (LN 2 ) or in -80°C showed long-term stable values for routine tests for a period of over 12 months, and 6 months for FVIII. Interestingly, the activated partial thromboplastin time (aPTT) showed a temporary significant prolongation over the first two weeks. Plasma frozen and stored in -40°C is not viable for aPTT and FVIII testing, otherwise it can be used for other parameters for up to 4 months. PS showed a significant increase in all frozen samples. Freezing rate has a significant impact on plasma quality and the final storage temperature influences the long-term stability. CONCLUSION: The optimal storage conditions are ultra-low temperatures (LN 2 or -80°C) and the highest freezing rate possible. However, frozen plasma is not viable for IQC of aPTT during a period of two weeks after freezing. This study is unique in its conception as a practical guide for the handling of frozen plasma samples in modern laboratory settings.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016323
- 003
- CZ-PrNML
- 005
- 20231026110028.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MBC.0000000000001239 $2 doi
- 035 __
- $a (PubMed)37577899
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Fenclova, Tereza $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis $u Charles University, First Faculty of Medicine, Prague, Czech Republic
- 245 10
- $a Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma / $c T. Fenclova, F. Marecek, I. Hrachovinova
- 520 9_
- $a OBJECTIVES: Degradation of coagulation proteins in frozen plasma may influence assay results. The aims of this study were to explore the changes in coagulation parameters in patient plasma and internal quality control (IQC) after different freezing and storage conditions during the short-term and long-term periods. METHODS: Platelet poor plasma was prepared from citrated peripheral blood collected from a group of healthy donors. The plasma was pooled, frozen and stored in a variety of freezing and storage conditions. The changes were monitored using routine coagulation assays, as well as factor VIII (FVIII) and protein S (PS) assays. RESULTS: Plasma stored in liquid nitrogen (LN 2 ) or in -80°C showed long-term stable values for routine tests for a period of over 12 months, and 6 months for FVIII. Interestingly, the activated partial thromboplastin time (aPTT) showed a temporary significant prolongation over the first two weeks. Plasma frozen and stored in -40°C is not viable for aPTT and FVIII testing, otherwise it can be used for other parameters for up to 4 months. PS showed a significant increase in all frozen samples. Freezing rate has a significant impact on plasma quality and the final storage temperature influences the long-term stability. CONCLUSION: The optimal storage conditions are ultra-low temperatures (LN 2 or -80°C) and the highest freezing rate possible. However, frozen plasma is not viable for IQC of aPTT during a period of two weeks after freezing. This study is unique in its conception as a practical guide for the handling of frozen plasma samples in modern laboratory settings.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zmrazování $7 D005615
- 650 12
- $a krevní plazma $7 D010949
- 650 _2
- $a parciální tromboplastinový čas $7 D010314
- 650 _2
- $a hemokoagulace $7 D001777
- 650 _2
- $a vyšetření krevní srážlivosti $7 D001780
- 650 12
- $a hemostatika $7 D006490
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Marecek, Frantisek $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis
- 700 1_
- $a Hrachovinova, Ingrid $u Institute of Hematology and Blood Transfusion, National Reference Laboratory for Disorders in Hemostasis
- 773 0_
- $w MED00009346 $t Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis $x 1473-5733 $g Roč. 34, č. 6 (2023), s. 377-384
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37577899 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110023 $b ABA008
- 999 __
- $a ok $b bmc $g 2000063 $s 1202685
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 34 $c 6 $d 377-384 $e 20230719 $i 1473-5733 $m Blood coagulation & fibrinolysis $n Blood Coagul Fibrinolysis $x MED00009346
- LZP __
- $a Pubmed-20231013